Our Work

REACH 2.0 is a three-year strategic plan by SHARE INDIA to expand comprehensive non-communicable disease screening across 24 villages in Medchal through a structured, sequential rollout.

The Longitudinal Indian Family Health (LIFE) pilot study was established in 2009. The goal of this study is to understand the link between the environment in which Indian women conceive, pregnancy, and child birth, physical and mental health along with the development of the child.

As part of the Clinical Trial Network established under the National Biopharma Mission through the Biotechnology Industry Research Assistance Council, ten demographic surveillance sites across India were selected to study the epidemiology of acute febrile illnesses, dengue, & chikungunya

STReTCH is a community- and family-based screening program in rural Telangana that integrates molecular diagnostics to identify and manage hypertension, diabetes, tuberculosis, and cervical cancer.

SHARE INDIA jointly with Johns Hopkins University to evaluate various strategies in screening the population for Cervical Cancer. The project was initiated in 2002 and completed in 2009, under the guidance of Prof. Keerti Shah and implemented by his associate Dr. Patti Gravitt.

The Prosthetics & Orthotics for the Differently Abled Program (POP) is an innovation-led initiative focused on developing affordable, customized prosthetic and orthotic solutions in India. By integrating digital technologies with clinical expertise, POP aims to restore mobility, independence, and dignity for persons with limb loss.

Artificial Heart Program (AHP) is a flagship bio-engineering initiative by SHARE INDIA that brings together engineering institutes, medical institutions, and industry partners to advance the indigenous development of life-saving cardiac assist devices in India through collaborative, innovation-driven research.

SHARE INDIA provides technical assistance under cooperative agreements supported by the Centers for Disease Control and Prevention and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to strengthen India’s response to HIV and tuberculosis. Working in close collaboration with national and state health programs, our efforts span disease surveillance systems, laboratory strengthening, diagnostics, treatment optimization, and digital health platforms—advancing data-driven decision-making to accelerate epidemic control and TB elimination.

Supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria, SHARE INDIA is strengthening India’s national HIV laboratory systems under NACP by expanding drug resistance testing, improving quality standards, and advancing molecular surveillance. From establishing HIV-1 Drug Resistance laboratories and a national biorepository to scaling ISO 15189–aligned quality systems, this initiative enhances diagnostic accuracy, informs treatment decisions, and strengthens India’s capacity to detect and respond to emerging HIV threats.

The Indian Council of Medical Research (ICMR) the apex governing. body in India for the formulation, coordination and promotion of biomedical research selected SHARE INDIA and MediCiti Institute of Medical Sciences (MIMS) as s sub site of Bhagwan Mahavir Medical Research Center (MMMRC) for a vaccine study.

This longitudinal study, initiated in 2012, was designed to examine the burden of age-related chronic diseases and associated risk factors among older adults in rural India. The study was implemented in the Medchal region of Telangana, through collaboration between SHARE INDIA, MediCiti Institute of Medical Sciences

Metabolic Syndrome (MetS) is a cluster of metabolic abnormalities—including central obesity hypertension, dyslipidemia, and hyperglycemia—that increase the risk of cardiovascular disease and type 2 diabetes. While MetS prevalence in urban Indian populations is reported to be high (approximately one in three adults), limited data exist for tribal populations.

A weak Quality Management System (QMS) may result in laboratory errors that can lead to both over- and under-diagnosis of TB, interruptions in service, and delayed reporting of results, leading to a negative impact on patient care.

HEALS studies the impact of environmental exposures air pollutants (PM2.5, NO2, O3) and extreme temperatures on health across the life course in India and the US. The project combines high-resolution environmental data with multi-cohort health assessments to generate evidence for policy and preventive interventions.

Stillbirths are a hidden tragedy that impacts millions of women and families across the globe daily. The stillbirth rate is one of the indicators of the quality of a country's healthcare system. Stillbirths are a significant public health problem in India.

The Cervical Cancer Care Initiative (CCCI) is implemented in five villages of Medchal-Malkajgiri district, Telangana. The initiative combines formative research, advocacy, and community engagement to improve vaccine acceptance and cervical cancer prevention.

Surgical site infections are one of the most common associated infections in the low middle-income countries. As per studies conducted in India, they make up to 14-16% of inpatient infections.

This study explores the relationship between maternal weight and early pancreatic beta cell function in infants. Pancreatic beta cells play a critical role in insulin production and regulation of blood glucose levels, which are essential for metabolic health.

A community-based, descriptive prospective seroprevalence study designed to determine the prevalence of specific antibodies ( IgG ) against dengue in healthy 5 to 10 year old children across 10 sites in India of which two sites, 006 (Gundlapochampally) and 007 (Ravalkol) were allocated to SHARE INDIA

Ramaiah Medical College and Indian CST’s – ICMR funded project which supports NTEP’s existing guidelines to treat TB in high-risk groups (socially vulnerable and clinically high risk) and to reach the unreachable for the screening of TB and LTBI among rickshaw drivers and construction workers.

Reproductive tract infections (RTI) present major health, social, and economic problems for women in developing countries. The objective is to understand pregnancy outcomes due to reproductive tract infections in India.

Studies conducted earlier across the globe have demonstrated that, a homogeneous Lactobacillus-dominated microbiome has long been considered the hallmark of health in the female reproductive tract.

Early pregnancy loss is non-induced embryonic or fatal death or passage of products of conception before 20 weeks’ gestation. Early pregnancy loss is also termed as spontaneous abortion or miscarriage.

A healthcare model where trained non-physician health workers use tablet-based mHealth tools and point-of-care devices to screen for hypertension and diabetes, connect patients to doctors via telemedicine, provide e-prescriptions, and deliver medicines to their doorstep, with follow-ups every three months.

Hypertensive disorders of the pregnancy cover a spectrum of conditions including preeclampsia, eclampsia, chronic hypertension and preeclampsia superimposed on chronic hypertension.

Computational model can help society translate observations into an anticipation of future events, act as a test bed for ideas, extract value from data and ask questions about behaviors.

Modern pathology laboratories are providing Point of Care (POC) services to the needy. However, often these are inaccessible and not affordable to patients living in rural areas.

The burden of animal bites and human rabies deaths in India, assess post-exposure prophylaxis (PEP) coverage, and describe the anti-rabies vaccine (ARV) supply chain, and estimate the costs associated with animal bites. The study used a cross-sectional survey design with three components.

This ongoing community-based cross-sectional study was conducted in the Medchal Mandals of Medchal-Malkajgiri district, Telangana, covering a population of approximately 50,000 across 8,400 households.

Globally, high systolic blood pressure (SBP) was reported as the leading risk factor for morbidity and mortality. Hypertension is also a leading cause of death and disability in India with a prevalence of 30%. Significant variation was noted in hypertension prevalence among rural (28%) and urban (34%) patients in India.

India has made significant progress in reducing maternal mortality over the past two decades; however, the burden remains substantial, and achieving the Sustainable Development Goal target by 2030 requires continued efforts.

An approach involving the follow-up of a defined population cohort through repeated serological surveys and syndromic acute febrile illness/influenza-like illness surveillance via fortnightly phone calls (without laboratory confirmation) to record suspected cases of COVID-19.

LaQSH Plus is a national laboratory systems strengthening initiative implemented under the CDC–PEPFAR cooperative agreement. The project provides strategic technical assistance to NACO under the National AIDS Control Programme (NACP), supporting progress toward the 95–95–95 HIV targets.

NISCHIT Plus (HIV) provides targeted technical assistance to strengthen HIV service delivery, advance differentiated care, and enhance treatment quality for people living with HIV (PLHIV) across all districts of Andhra Pradesh, in collaboration with the Andhra Pradesh State AIDS Control Society (APSACS).

NISCHIT Plus (TB) provides technical assistance to the National TB Elimination Program (NTEP) under the Ministry of Health and Family Welfare, Government of India, in collaboration with the Central TB Division and State TB Offices.

Under the BOLSTER initiative, SHARE INDIA works with the Government of India and the Centers for Disease Control and Prevention (CDC) to strengthen India’s capacity to prevent, detect, and respond to infectious disease threats.

Rural Effective Affordable Comprehensive Health Care (REACH) is one of the flagship programs of SHARE INDIA. It was developed as a working model of a proactive healthcare delivery system that offers promotive, preventive, and primary healthcare to rural populations.

SHARE INDIA and Birla Institute of Technology and Science, Hyderabad Campus developed a low-cost ARI monitor that measures key infant vital signs (HR, RR, SpO₂, temperature) and displays real-time data on mobile devices.